Companies and Drugs - Search News

The New York Times · 20h

Novo Nordisk Annual Sales Jump on Higher Demand for Obesity Drugs

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year.

Novo Nordisk defends next-gen obesity drug CagriSema, gives details of new trial

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data published in December that disappointed investors and wiped $125 billion from its market value.

The Financial Times · 1d

Obesity drug sales help Novo Nordisk beat expectations

Sales of Novo Nordisk’s obesity drug, Wegovy, rose by more than 50 per cent last year, helping the Danish drugmaker beat revenue expectations. The company on Wednesday reported that net sales increased by 26 per cent year on year in 2024 to DKr290bn ($40bn),

Barron's on MSN · 23h

Novo Nordisk Expects Positive News on Weight-Loss Drugs, Soon, From FDA

The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from legally selling cheap knockoff versions.

2hon MSN

Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected

Eli Lilly expects to read out results from a study in people with obesity and osteoarthritis of the knee in 2025.

5don MSN

Elizabeth Warren grilled RFK Jr on drug company money, but received over $5M from health industry

Mass., grilled Robert F. Kennedy Jr. over his plans to profit off of drug companies or lawsuits after being Health and Human ...

Family claims Dr. Bronner’s fosters a risky culture of drug use that led to employee’s accidental overdose death

A wrongful death lawsuit alleges the company fostered a risky culture of drug use among some leaders and employees, claiming ...

U.S. taxpayers should stop funding clinical trials of industry-owned drugs

I worked closely with NCI’s Investigational Drug Branch (IDB) from 1990-2016, including as a principal investigator of one of ...

1d

Lilly needs a plan to spur weight-loss drug sales, investors say

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

Amid more drug-price scrutiny, biopharma companies largely keep their January hikes in check

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

6d

Why Weight-Loss Drugs Could Be Game-Changers for Your Investment Portfolio

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

1don MSN

FDA approves first new non-opioid painkiller in decades, and it's from a MA company.

The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex ...

20h

Wisconsin couple sues Walgreens and Optum Rx, saying son died after $500 price rise for asthma meds

A Wisconsin couple is suing Walgreens and a pharmacy benefits company alleging their son died because he couldn't afford a ...

Bills aim to address prescription drug costs, pharmacy closures by regulating PBMs

Pharmacy benefit managers, insurance companies, and pharmacists debated the causes and potential impacts of the new proposal ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results